Following positive trial data , retatrutide, a novel peptide treatment for managing non-insulin dependent metabolic disorder, has obtained regulatory approval from the Medicines and Healthcare Agency (MHRA https://shopretatrutidepeptide.com/category/retatrutide-peptide/